Clinical trials for Metastatic renal cell carcinoma investigate a range of treatment strategies and patient populations.

21 total trials for this combination

Showing top 10 of 21 trials

Trials

NCT ID	Title	Status	Phase
NCT04510597	Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial	RECRUITING	PHASE3
NCT03055013	Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy	ACTIVE_NOT_RECRUITING	—
NCT02231749	Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)	COMPLETED	PHASE3
NCT01582672	Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma	TERMINATED	PHASE3
NCT03428217	CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma	COMPLETED	PHASE2
NCT00410124	RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib	COMPLETED	PHASE3
NCT06500455	Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain	RECRUITING	PHASE3
NCT04514484	Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV	ACTIVE_NOT_RECRUITING	PHASE1
NCT03595124	A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)	ACTIVE_NOT_RECRUITING	PHASE2
NCT05327686	Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial	RECRUITING	PHASE2

Related Pages

All Metastatic renal cell carcinoma trials All trials in Pittsburgh, United States